Yaron Daniely, PhD, MBA, CEO of Alcobra Pharma, talks about the problems with current medications for ADHD. First class medications against ADHD include scheduled stimulants such as Ritalin, Adderall,…
Martin Lee, director, Project CBD, talks about the JAMA article that highlights the 25 percent decrease in overdose deaths from opiates in states where medical marijuana is legal. According…
Martin Lee, director, Project CBD talks about the medical benefits of cannabidiol (CBD). CBD is the non-psychoactive compound in cannabis, and can serve as an effective therapy for cardiovascular disease,…
John Weinberg, MD, COO, Veloxis Pharmaceuticals, talks about the challenges in current organ transplantation methods, and Veloxis’ once-daily solution to advancing kidney transplantation. According to Weinberg, most kidney transplants…
Jose Cavazos, MD, Professor of Medicine – Neurology & Physiology, Associate Professor of Pharmacology at University of Texas Health Science Center at San Antonio, discusses responsive neurological stimulation…
Agitation is common in patients with Alzheimer’s disease. It is often expressed as aggression, excessive activity or hostility. A new study examined whether the anti-depressant drug citalopram is…
Steven Mento, PhD, Co-Founder, President & CEO, Conatus Pharmaceuticals, addresses the need for a better understanding of the causes of liver disease. Conatus’s latest project, Emricasan, a therapy for…
The Food and Drug Administration, the oldest comprehensive consumer protection agency in the U.S. federal government, is charged with protecting the public health. Under this mandate, it regulates…
When a new drug is approved by the U.S. Food and Drug Administration, it is assume to be safe and effective. But are all drug approvals created equal?…
Calcium plaque in the arteries of the heart is a sign of changes that can lead to heart attacks. To measure this calcium physicians sometimes use a form…